Dr. Carter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-0489Fax+1 319-353-8383
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1987- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1983 - 1986
Case Western Reserve University School of MedicineClass of 1983
Certifications & Licensure
IA State Medical License 2001 - 2020
OH State Medical License 1986 - 2003
OK State Medical License 1990 - 2001
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsGAS6 expression identifies high-risk adult AML patients: potential implications for therapy.Susan P. Whitman, Jessica Kohlschmidt, Kati Maharry, Stefano Volinia, Krzysztof Mrózek
Leukemia. 2014-06-01 - 205 citationsRUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA E...Jason H. Mendler, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Heiko Becker
Journal of Clinical Oncology. 2012-09-01 - 590 citationsIDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Yue-Zhong Wu, Michael D. Radmacher, Krzysztof Mrózek
Journal of Clinical Oncology. 2010-05-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
